Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma to Present at the 12th Annual BIO CEO & Investor Conference
BOULDER, Colo., Feb 01, 2010 (BUSINESS WIRE) -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the 12th Annual BIO CEO & Investor Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma Web site.


12th Annual BIO CEO & Investor Conference


Robert E. Conway, Chief Executive Officer, Array BioPharma


Monday, February 8, 2010


9 a.m. Eastern Time


The Waldorf=Astoria, New York City


About Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. For more information on Array, please go to

SOURCE: Array BioPharma Inc.

Array BioPharma Inc.
Tricia Haugeto, 303-386-1193